EU Listing Act streamlines SME market access with simplified disclosure, lower costs, and faster capital raising, making EU listings more accessible for growth.
Small-cap issuers can close the small-cap coverage gap by strengthening investor relations, using digital tools, and engaging independent research.
Issuer-Sponsored Equity Research in the EU: ESMA and MiFID II set clear standards for transparency, disclosure, and investor protection in research.
EU capital markets face regulatory shifts, evolving valuations, and new risks in 2026. Independent equity research offers clarity for informed investment decisions.
Investor Relations and independent equity research boost small- and mid-cap issuer visibility, attract investors, and support fair market valuation.
Compare sponsored research and sell-side analysis, examining global standards for analyst independence, disclosure, and safeguards to ensure unbiased equity research.
Overcome the liquidity trap in Brazil’s B3 small-cap market with strategies for efficient trading, risk management, and improved market access.
Lithium Triangle Outlook: Assessing junior miners’ prospects, challenges, and opportunities in Chile, Argentina, and Bolivia’s lithium sector.
CRISPR vs. mRNA: Which offers better long-term vision? CRISPR enables lasting genetic changes, while mRNA excels in rapid, adaptable therapies.
Cybersecurity after CrowdStrike opens doors for niche competitors to address gaps, innovate with specialized solutions, and challenge market leaders.